Quantitative PET imaging of PD-L1 expression in xenograft and syngeneic tumour modelsRead story
Minerva Imaging is a scientifically driven CRO founded in 2011.
Our focus is on the use of advanced oncology models and molecular imaging for translational cancer research and drug development.
We have extensive experience in design and execution of pre-clinical studies for drug development within oncology.
We have substantial experience in performing studies with targeted radionuclide therapy in oncology.
Building on more than two decades of research in Nuclear Medicine we are proficient in conducting molecular imaging.
We have in-depth knowledge in cardiovascular disease and advanced imaging to study drug interventions.
We engage with our clients to understand their scientific questions and discuss how our methods and capabilities can provide answers.
Optimal results require attention to details
We engage with our clients to understand their scientific questions and discuss how our methods and capabilities can provide answers. Our competences build on more than two decades of research within oncology and molecular imaging performed at the University of Copenhagen and Rigshospitalet, the National University Hospital of Denmark.Read about us
New publication on PET imaging
Minerva Imaging is presenting at the AACR-NCI-EORTC 2019
Minerva Imaging is presenting at the AACR-NCI-EORTC Conference 2019Read story